Insourcing vs. Outsourcing pharmaceutical software development — the tradeoffs

AuthorTeodora Corbu

CategoryPharma Innovation

When should you outsource and when it's best to do everything in-house? We have a few answers in this article.

The pharmaceutical industry constantly evolves, and software development plays an increasingly important role. Pharmaceutical software is critical to innovation, efficiency, and regulatory compliance.

There are two main approaches to pharmaceutical software development: insourcing vs outsourcing. As the name suggests, the first implies that the software will be developed in-house, while the second means hiring a third party vendor to do the work.

As with anything, there are pros and cons to each strategy. Insourcing can offer greater control over the development process and access to specialized expertise. Nevertheless, it can be more expensive and time-consuming. Outsourcing can save you money and time, but if you don’t choose your partner well, it can lead to quality control issues and security risks.

The decision between insourcing and outsourcing is not something to take lightly. There is no one-size-fits-all solution; the best approach will vary depending on your organization's specific needs.

As we venture deeper into this comparison, it becomes evident that the insourcing and outsourcing of pharma software are not just operational choices but strategic decisions that can shape the future of the pharma industry.

Join us on this journey as we uncover the intricacies, nuances, and, ultimately, the tradeoffs inherent in this pivotal decision-making process.

1. Insourcing software development in pharma

Insourcing involves developing the software in-house, using the company’s own employees and resources, rather than outsourcing them to third party vendors or external development teams. Using an internal team for pharma application development has pros and cons, but let’s start with the advantages and finish with the disadvantages.

1.1 Advantages of insourcing

1.1.1 Control and security

Control and security are two of the most important factors to consider when choosing to insource pharma software development. 

Control implies having the ability to manage the development process and make sure that the application meets its specific needs and requirements. This includes managing the design, development, testing, and deployment.

In-house teams can customize applications to align with the organization’s unique workflows, processes, and data-handling requirements. This can mean more efficient operations and better integration with existing systems.

Additionally, working in-house also means immediate responses. When issues or changes arise during software development, the team can respond quickly and make necessary changes. This agility can be crucial in a dynamic and highly regulated industry like pharma.

Security means protecting the software from unauthorized access, use, disclosure, modification, or even destruction and ensuring it complies with all applicable regulations.

By avoiding third party vendors or contractors, pharma companies can reduce the risk of sharing sensitive data with external entities. This way, the chance of data leakage or breaches is minimized.

While insourcing offers significant control and security advantages, pharma organizations must realize that these benefits come with increased responsibility. This means investing in cybersecurity measures, implementing robust access controls, conducting regular audits, and ensuring the team members are trained in security best practices.

Even more, staying current with evolving security threats and regulatory changes is vital to maintaining the highest level of data security in pharma software development.

1.1.2 Expertise and knowledge retention

When pharma companies work with an inhouse team, they ensure that the people involved in the process have the necessary expertise to develop the application effectively. This is important in the pharma industry since it often requires specialized knowledge.

Insourcing offers the opportunity for ongoing learning and skill development. Your team can stay updated with the latest industry trends, technologies, and regulatory changes. The teams understand the intricacies of the pharma industry - valuable specialized knowledge.

Additionally, companies can establish quality control capabilities - ensuring that the software meets the highest quality and compliance standards, reducing the risk of costly errors and regulatory setbacks.

Knowledge retention means having a company's ability to retain its employees' knowledge and skills. Insourcing implies providing the team with training and development opportunities. This is important since they must stay current on the latest technologies and best practices.

External vendors may change over time, leading to knowledge loss when critical personnel leave. With insourcing, the organization has more control over employee retention and can mitigate the impact of turnover by implementing knowledge transfer and succession planning strategies.

Even though expertise and knowledge retention are clear advantages of insourcing, pharma organizations should know the importance of continuous training and development to keep their teams up-to-date with the latest technologies and industry best practices.

1.1.3 Alignment with organizational goals

When companies insource software development, they can ensure that the application is developed to support the company’s goal. This is important since this kind of software is often used to achieve specific business objectives.

An insourced team can easily design an application that integrates seamlessly with the organization's other systems and technologies. This can enhance efficiency and ensure the application aligns with the broader IT infrastructure and goals. 

This alignment helps achieve current objectives and positions the organization for continued success and competitiveness in the evolving pharma landscape.

1.2 Challenges and limitations

1.2.1 Cost considerations

The cost is a critical aspect of insourcing a development project. Even though insourced teams come with benefits like complete control and alignment, they also come with costs and financial implications. Let’s take a look at the main cost considerations you should have in mind:

  1. Initial setup costs

  2. Operating costs

Free Webinar

Insourcing vs. Outsourcing in Pharma

Andrew Binns from AstraZeneca UK, Erasmus Holm from MSD Netherlands, and Matt Lowe from Performance-io talk about the advantages, challenges, and trends in insourcing and outsourcing

2. Outsourcing software development in pharma

Outsourcing software development involves hiring external third party vendors or development teams to design, develop, and maintain software solutions tailored to the specific needs of pharma companies.

Just like with insourcing, there are pros and cons to this approach. Let’s discuss each.

2.1 Advantages of outsourcing

2.1.1 Cost savings and efficiency

This is one of the most significant outsourcing pros. Let’s explore these cost savings and efficiency increases that come with outsourcing:

  1. Labor cost savings

  2. Easy access to specialized expertise

Free Webinar

Launching Global to Regional and Local Projects in Pharma

Five pharma industry experts shared their experience in implementing and adjusting global strategies on a regional and local level

3. The tradeoffs of insourcing vs. outsourcing pharma software development

Let's make a side-by-side comparison to better underline the difference between outsourcing and insourcing.

Factor

Insourcing Software Development

Outsourcing Software Development

Cost

Initial costs may be higher due to resource setup.

Often more cost-effective due to lower labor expenses.

Long-term operational costs may be lower.

Predictable and controlled budgeting through contracts.

May involve overhead expenses for in-house operations.

Reduced in-house operational overhead costs.

Cost conclusion

Can be more expensive, as companies have to invest in hiring and training staff and purchasing hardware and software.

Can save companies money on development costs, as they do not have to invest in hiring staff or purchasing hardware and software.

Time to market

May face delays due to resource constraints and learning curve.

May face delays due to resource constraints and learning curve.
Potential for faster project initiation and execution.

In-house teams may prioritize other core activities.

Ability to meet tight deadlines with experienced teams.

Project timelines can be more challenging to predict.

Can adapt to changing project needs more efficiently.

Time to market conclusion

Can take longer, as companies have to go through the entire development process in-house.

Can help companies get their software to market faster, as they do not have to go through the entire development process in-house.

Control

High level of control over the development process and team.

Reduced control over the development process and team.

Direct oversight of in-house personnel.

Reliance on outsourcing partners for quality and progress.

Ability to make real-time adjustments and changes.

Monitoring and oversight may require additional effort.

Control conclusion

Companies have more control over the development process.

Companies have less control over the development process, as they depend on the outsourcing vendor.

Risk

Direct control over data security and confidentiality.

Requires clear data security agreements and oversight.

In-house expertise in data protection and compliance.

Risk of data breaches if security measures are inadequate.

Data is handled and stored internally, reducing risks.

Potential exposure of sensitive data to external partners.

Direct management of quality assurance and validation.

Compliance expertise provided by the outsourcing partner.

In-house teams can implement rigorous testing standards.

Risk of inadequate quality control without proper oversight.

Close alignment with pharmaceutical regulations and standards.

Need for clear quality control protocols and audits.

Risk conclusion

There is a risk of quality control issues and security breaches due to resource limitations.

There is a risk of communication challenges and vendor lock-in.

Flexibility

Resources can be limited, leading to project delays.

Scalability allows for efficient resource allocation.

Dependence on hiring and retaining skilled personnel.

Can rapidly scale up or down based on project needs.

Risk of resource turnover and project disruptions.

Availability of a global talent pool for specific needs.

Flexibility conclusion

Less flexible, as companies cannot easily scale up or down their development needs.

More flexible, as companies can scale up or down their development needs as needed.

Access to specialized expertise

Companies may not have access to specialized expertise in-house.

Companies can gain access to specialized expertise that they may not have in-house.

4. Choosing the right approach for your organization

Ultimately, the best approach for a pharma company will depend on its specific needs and circumstances. If you want to save money and get the software solution to market faster, outsourcing might be the best option.

However, if you want more control over the development process, you should consider insourcing.

Let’s list some factors that should be considered when deciding between insourcing vs. outsourcing:

  • The size and complexity of the project - larger and more complex projects may be more challenging to insource, as they require a higher level of expertise and coordination.

  • The budget - outsourcing can help you with saving money in the long run by reducing the risk of quality control issues and security issues.

  • The timeline - insourcing can take longer than outsourcing, and the latter can give your organization more flexibility.

  • The company’s in-house capabilities - insourcing may be the best option if the company has the necessary expertise and resources to develop the software in-house.

  • The company’s culture - some companies prefer to have more control over the development process, while others are more comfortable with outsourcing.

By carefully considering all the factors mentioned in this article, you should be able to make the best decision for the specific needs of your pharmaceutical company.

PharmaGermany flagGermany
PharmaGermany flagGermany

Unified HCP portal: from fragmentation to integration

One personalized platform replacing fragmented brand and medical sites.

Unified HCP portal: from fragmentation to integration

Browse more related content